Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma

Journal of Biomedical Science

Volumn 16, Issue 1, 2009, Pages

  Pu, Yeong Shiau ^a   Huang, Chao Yuan ^a   Kuo, Yi Zih ^b   Kang, Wang Yi ^d   Liu, Guang Yaw ^c   Huang, A Mei ^b   Yu, Hong Jeng ^a   Lai, Ming Kuen ^a   Huang, Shu Pin ^e   Wu, Wen Jeng ^e   Chiou, Shean Jaw ^b   Hour, Tzyh Chyuan ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d KUO GENERAL HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CELL MEMBRANE; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY CORTEX; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING; AGED; ANTIBODY SPECIFICITY; CHEMISTRY; COMPARATIVE STUDY; KAPLAN MEIER METHOD; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; NEPHRECTOMY; ULTRASTRUCTURE;

AGED; CARCINOMA, RENAL CELL; CELL MEMBRANE; CYTOPLASM; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY CORTEX; KIDNEY NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEPHRECTOMY; ORGAN SPECIFICITY; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 70349508927     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-16-82     Document Type: Article

References (51)

1. Renal-cell carcinoma. HT Cohen FJ McGovern, N Engl J Med 2005 353 2477 2490
2. Renal cell carcinoma: new prognostic factors? Z Kirkali M Lekili, Curr Opin Urol 2003 13 433 438 (Pubitemid 38186761)
3. Targeted therapy for metastatic renal cell carcinoma. RJ Motzer RM Bukowski, J Clin Oncol 2006 24 5601 5608
4. Molecular markers for early detection of renal carcinoma: investigative approach. S Skates O Iliopoulos, Clin Cancer Res 2004 10 6296 6301
5. Prognostic factors and molecular markers for renal cell carcinoma. MH Bui A Zisman AJ Pantuck KR Han J Wieder AS Belldegrun, Expert Rev Anticancer Ther 2001 1 565 575
6. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. S Higashiyama H Iwabuki C Morimoto M Hieda H Inoue N Matsushita, Cancer Sci 2008 99 214 220
7. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. S Higashiyama H Iwabuki C Morimoto M Hieda H Inoue N Matsushita, Cancer Sci 2008 99 214 220
8. The status and role of ErbB receptors in human cancer. I Uberall Z Kolar R Trojanec J Berkovcova M Hajduch, Exp Mol Pathol 2008 84 79 89
9. Growth factors and receptors as prognostic markers in urothelial carcinoma. PC Black CP Dinney, Curr Urol Rep 2008 9 55 61
10. EGFR inhibitor-mediated apoptosis in solid tumors. S Goel M Hidalgo R Perez-Soler, J Exp Ther Oncol 2007 6 305 320
11. The epidermal growth factor receptor: from development to tumorigenesis. M Sibilia R Kroismayr BM Lichtenberger A Natarajan M Hecking M Holcmann, Differentiation 2007 75 770 787
12. The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. DJ Chen CS Nirodi, Clin Cancer Res 2007 13 6555 6560
13. Studies of the expression of epidermal growth factor receptor in human renal cell carcinoma: a comparison of immunohistochemical method versus ligand binding assay. K Yoshida Y Hosoya S Sumi M Honda H Moriguchi M Yano Y Ueda, Oncology 1997 54 220 225
14. Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer 34. AS Merseburger J Hennenlotter P Simon S Kruck E Koch M Horstmann U Kuehs R Kufer A Stenzl MA Kuczyk, Anticancer Res 2005 25 1901 1907
15. Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma. J Ishikawa S Maeda K Umezu T Sugiyama S Kamidono, Int J Cancer 1990 45 1018 1021 10.1002/ijc.2910450606
16. Epidermal growth factor receptor content in human renal cell carcinomas. K Yoshida A Tosaka S Takeuchi N Kobayashi, Cancer 1994 73 1913 1918
17. EGFR antagonists in cancer treatment. F Ciardiello G Tortora, N Engl J Med 2008 358 1160 1174
18. The treatment of metastasis from renal cell carcinoma 30. S Khoury, Prog Clin Biol Res 1982 100 541 547
19. New trends in the diagnosis and treatment of renal cell carcinoma 14. A Zisman, Harefuah 2002 141 713 7
20. Cytoplasmic/nuclear shuttling and tumor progression. SC Wang MC Hung, Ann N Y Acad Sci 2005 1059 11 15
21. Nuclear localization of EGF receptor and its potential new role as a transcription factor. SY Lin K Makino W Xia A Matin Y Wen KY Kwong L Bourguignon MC Hung, Nat Cell Biol 2001 3 802 808 10.1038/ncb0901-802 11533659
22. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. HW Lo SC Hsu M li-Seyed M Gunduz W Xia Y Wei G Bartholomeusz JY Shih MC Hung, Cancer Cell 2005 7 575 589
23. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. HW Lo SC Hsu MC Hung, Breast Cancer Res Treat 2006 95 211 218
24. Cytoplasmic/nuclear shuttling and tumor progression. SC Wang MC Hung, Ann N Y Acad Sci 2005 1059 11 15
25. Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. JP Kallio P Hirvikoski H Helin P Kellokumpu-Lehtinen T Luukkaala TL Tammela PM Martikainen, Br J Cancer 2003 89 1266 1269
26. Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? C Langner M Ratschek P Rehak L Schips R Zigeuner, J Clin Pathol 2004 57 773 775
27. Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. JP Kallio P Hirvikoski H Helin P Kellokumpu-Lehtinen T Luukkaala TL Tammela PM Martikainen, Br J Cancer 2003 89 1266 1269
28. Prognostic significance of morphologic parameters in renal cell carcinoma. SA Fuhrman LC Lasky C Limas, Am J Surg Pathol 1982 6 655 663
29. FL Greene DL Page ID Fleming A Fritz CM Balch DG Haller M Morrow, AJCC Cancer Staging Manual New York: Springer-Verlag 6 2002
30. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. FR Hirsch M Varella-Garcia PA Bunn Jr MV Di Maria R Veve RM Bremmes AE Baron C Zeng WA Franklin, J Clin Oncol 2003 21 3798 3807
31. Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? C Langner M Ratschek P Rehak L Schips R Zigeuner, J Clin Pathol 2004 57 773 775
32. The status and role of ErbB receptors in human cancer. I Uberall Z Kolar R Trojanec J Berkovcova M Hajduch, Exp Mol Pathol 2008 84 79 89
33. Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer 34. AS Merseburger J Hennenlotter P Simon S Kruck E Koch M Horstmann U Kuehs R Kufer A Stenzl MA Kuczyk, Anticancer Res 2005 25 1901 1907
34. Pharmacogenetics of EGFR and VEGF inhibition. J Pander H Gelderblom HJ Guchelaar, Drug Discov Today 2007 12 1054 1060
35. Prognostic factors and molecular markers for renal cell carcinoma. MH Bui A Zisman AJ Pantuck KR Han J Wieder AS Belldegrun, Expert Rev Anticancer Ther 2001 1 565 575
36. The epidermal growth factor receptor: from development to tumorigenesis. M Sibilia R Kroismayr BM Lichtenberger A Natarajan M Hecking M Holcmann, Differentiation 2007 75 770 787
37. Targeted agents for the treatment of advanced renal cell carcinoma. WM Stadler, Cancer 2005 104 2323 2333
38. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact. G Hofmockel S Riess ID Bassukas J Dammrich, Eur Urol 1997 31 478 484
39. Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. JP Kallio P Hirvikoski H Helin P Kellokumpu-Lehtinen T Luukkaala TL Tammela PM Martikainen, Br J Cancer 2003 89 1266 1269
40. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis. DL Uhlman P Nguyen JC Manivel G Zhang K Hagen E Fraley D Aeppli GA Niehans, Clin Cancer Res 1995 1 913 920
41. EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization. H Moch G Sauter TC Gasser L Bubendorf J Richter JC Presti Jr FM Waldman MJ Mihatsch, J Pathol 1998 184 424 429
42. Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. JP Kallio P Hirvikoski H Helin P Kellokumpu-Lehtinen T Luukkaala TL Tammela PM Martikainen, Br J Cancer 2003 89 1266 1269
43. Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation? C Langner M Ratschek P Rehak L Schips R Zigeuner, J Clin Pathol 2004 57 773 775
44. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. CJ Piyathilake AR Frost U Manne H Weiss WC Bell DC Heimburger WE Grizzle, Clin Cancer Res 2002 8 734 744
45. Cytoplasmic accumulation of alpha-catenin is associated with aggressive features in laryngeal squamous-cell carcinoma. P Hirvikoski EJ Kumpulainen JA Virtaniemi HJ Helin I Rantala RT Johansson M Juhola VM Kosma, Int J Cancer 1998 79 546 550
46. Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. JP Kallio P Hirvikoski H Helin P Kellokumpu-Lehtinen T Luukkaala TL Tammela PM Martikainen, Br J Cancer 2003 89 1266 1269
47. Studies of the expression of epidermal growth factor receptor in human renal cell carcinoma: a comparison of immunohistochemical method versus ligand binding assay. K Yoshida Y Hosoya S Sumi M Honda H Moriguchi M Yano Y Ueda, Oncology 1997 54 220 225
48. The EGFR family and its ligands in human cancer signalling mechanisms and therapeutic opportunities. Y Yarden, Eur J Cancer 2001 37 Suppl 4 3 S8
49. Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: ligand and receptor dynamics. WA Dunn AL Hubbard, J Cell Biol 1984 98 2148 2159
50. Defective downregulation of receptor tyrosine kinases in cancer. KG Bache T Slagsvold H Stenmark, EMBO J 2004 23 2707 2712 10.1038/sj.emboj.7600292 15229652
51. Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. K Roepstorff L Grovdal M Grandal M Lerdrup DB van, Histochem Cell Biol 2008 129 563 578